Iridex (IRIX) is expanding its EyeProGPO product offering to include its line of EndoProbe Handpieces, which are single-use devices indicated for use with Iridex laser consoles for the treatment of retinal disorders in adult patients, the company said Monday.
Under an agreement, over 4,300 EyeProGPO members will have access to preferred pricing on Iridex EndoProbe Handpieces, according to a statement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.